Resistencia a la insulina: inflamación y obesidad|401
19.
Poher AL, Altirriba J, Veyrat-‐Durebex C y Rohner-‐Jeanrenaud F (2015) Brown
adipose tissue activity as a target for the treatment of obesity/insulin resistance
Front Physiol 6, 1 – 9.
20.
Reaven GM (1995) Pathophysiology of insulin resistance in human disease.
Physiol Rev 75, 473-‐486.
21.
Ros Pérez M y Medina-‐Gómez G (2011) Obesidad, adipogénesis y resistencia a la
insulina.
Endocrinol Nutr. 58, 360-‐369.
22.
Serrano-‐Rios M (2007) La Pandemia de Obesidad y sus consecuencias metabólicas.
Discurso. Real Academia Nacional de Medicina. Madrid.
23.
Serrano-‐Rios M y Gutierrez-‐Fuentes JM (2011) Obesity and type 2 diabetes
mellitus. The reciprocal impact. En: Obesity (eds Serrano-‐Rios, Ordovas JM y
Fuentes-‐Gutierrez JA. Elsevier pp 215-‐231.
24.
Shirai K (2004) Obesity as the core of the metabolic syndrome and the
management of coronary heart disease. Curr Med Res Opin 20, 295–304.
25.
Shoelson SE, Lee J, Goldfine AB (2006). Inflammation and insulin resistance. J Clin
Invest 116, 1793-‐801.
26.
Shoelson SE, Lee J, Yuan M (2003). Inflammation and the IKK beta/I kappa B/NF-‐
kappa B axis in obesity-‐ and diet-‐induced insulin resistance. Int J Obes Relat Metab
Disord. 27(Suppl 3), S49-‐S52.
